Eva Aggerholm Sædder

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Jesper Damsgaard Gunst, Marie H. Pahus, Lena Hagelskjær Kristensen et al. · EClinicalMedicine · 2021 · 197 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +3

Detection of Patients at High Risk of Medication Errors: Development and Validation of an Algorithm

Eva Aggerholm Sædder, Marianne Lisby, Lars Peter Nielsen et al. · Basic & Clinical Pharmacology & Toxicology · 2015 · 60 citations · Full text

Computing, Health Informatics, Clinical Decision Support +14

The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars

Thomas Bo Jensen, Dorthe Bartels, Eva Aggerholm Sædder et al. · European Journal of Clinical Pharmacology · 2019 · 60 citations · Full text

Pharmacy, Pharmacology, Drug Approval Processes +10

Pharmacokinetics, Tolerability, and Performance of a Novel Matrix Transdermal Delivery System of Fentanyl Relative to the Commercially Available Reservoir Formulation in Healthy Subjects

Jean‐Francois Marier, Mary Lor, Diane Potvin et al. · The Journal of Clinical Pharmacology · 2006 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial

Julie Schjødtz Hansen, Stefan Gustavsen, Homayoun Roshanisefat et al. · Pharmaceuticals · 2023 · 28 citations · Full text

Medicine, Neurology, Pharmacotherapy +16